* Conmed Corp CNMD.N reported quarterly adjusted earnings
of
$1.05 per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of 90 cents. The mean expectation of eight analysts for the
quarter was for earnings of 99 cents per share. Wall Street
expected results to range from 98 cents to $1.01 per share.
* Revenue rose 4% to $316.70 million from a year ago;
analysts
expected $318.13 million.
* Conmed Corp's reported EPS for the quarter was $1.57.
* The company reported quarterly net income of $48.98
million.
* Conmed Corp shares had fallen by 10.1% this quarter and
lost 40.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Conmed Corp is
$80.00
This summary was machine generated from LSEG data October 31 at
02:43 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.99 1.05 Beat
Jun. 30 2024 0.91 0.98 Beat
Mar. 31 2024 0.74 0.79 Beat
Dec. 31 2023 1.11 1.06 Missed